FDG PET-CT: Need for Vigilance in Patients Treated with Bleomycin. - Wikidata - wikimedia - TriplyDB

FDG PET-CT: Need for Vigilance in Patients Treated with Bleomycin.

FDG PET-CT: Need for Vigilance in Patients Treated with Bleomycin.

http://www.wikidata.org/entity/Q33711584

about

FDG PET-CT: Need for Vigilance in Patients Treated with Bleomycin.

http://www.wikidata.org/entity/Q33711584

description

2017 nî lūn-bûn

@nan

2017 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

FDG PET-CT: Need for Vigilance in Patients Treated with Bleomycin.

@ast

FDG PET-CT: Need for Vigilance in Patients Treated with Bleomycin.

@en

type

label

FDG PET-CT: Need for Vigilance in Patients Treated with Bleomycin.

@ast

FDG PET-CT: Need for Vigilance in Patients Treated with Bleomycin.

@en

prefLabel

FDG PET-CT: Need for Vigilance in Patients Treated with Bleomycin.

@ast

FDG PET-CT: Need for Vigilance in Patients Treated with Bleomycin.

@en

P1433

Q33711584-2FCD0AF3-BCF0-4FBC-94F8-1AC59F021981

P1476

Q33711584-795C78E8-8167-408B-945A-71DA76590EDA

P2093

Q33711584-778F44A5-60B7-45AF-BBF1-83303CEE0210

Q33711584-E83A87AF-C5DA-4005-A33E-615736B862A4

P2860

Q33711584-2E2DB331-41A3-44B7-BAC5-50A3A42C16B6

Q33711584-2FD1FA30-08BD-4632-8180-204737A188C6

Q33711584-7A9C58DB-B6DB-44C3-BE89-FBF563F6E30E

Q33711584-7C5F73AB-EEE8-47AB-9108-6DCC511026DD

Q33711584-A7C05F7F-DF21-4AB5-86FE-FBD0CB9D713F

Q33711584-C0774374-4EEE-415B-B635-D1BBC91C727E

Q33711584-C8227205-DF79-4605-B1E3-7665DBF74279

Q33711584-D17B6557-A3C6-47A6-83C2-62C963DB933D

Q33711584-D43050DE-4F1D-4E5A-9DB7-851F71C977E5

Q33711584-E17FFC09-71D9-4687-9EB8-8B665BDDAE15

P304

Q33711584-486F96D2-EE83-4AEE-BF16-4055B0DD9096

P31

Q33711584-DD062DC7-8854-4566-962B-089FCA094E75

Q33711584-ff0eb187-94b4-49e2-9188-87aa6f577e0a

P356

Q33711584-FF32F77E-43DC-4079-80E9-593836C66070

P433

Q33711584-A9F8643B-57F8-4B94-815C-9D0D95401A51

P478

Q33711584-6CCBB841-85BD-4DF0-A89E-F11BF057C31B

P50

Q33711584-401ABD33-6682-4A55-A335-A2233F7818B2

P577

Q33711584-915720DF-D83C-4C08-B708-4FEE6EC831F5

P698

Q33711584-59F11552-45EF-4A55-8911-F3D0CEEF4751

P932

Q33711584-1769AA49-5FC1-49C7-BE5F-02F69AF9FF89

P356

0972-3919.202242

P1433

Indian Journal of Nuclear Medicine

P1476

FDG PET-CT: Need for Vigilance in Patients Treated with Bleomycin.

@en

P2093

Anna N Paschali

http://www.w3.org/2001/XMLSchema#string

Gopinath Gnanasegaran

http://www.w3.org/2001/XMLSchema#string

P2860

Drug induced interstitial lung disease.

Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification

Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society.

Bleomycin-induced pulmonary toxicity.

Possible mechanisms of bleomycin-induced fibrosis.

Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma.

Pulmonary drug toxicity: FDG-PET findings in patients with lymphoma.

FDG-PET in bleomycin-induced pneumonitis following ABVD chemotherapy for Hodgkin's disease--a useful tool for monitoring pulmonary toxicity and disease activity.

FDG positron emission tomography/computerized tomography features of bleomycin-induced pneumonitis.

Increased Pulmonary FDG Uptake in Bleomycin-Associated Pneumonitis

P304

122-124

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4103/0972-3919.202242

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28533640

http://www.w3.org/2001/XMLSchema#string

P932

5439189

http://www.w3.org/2001/XMLSchema#string